Allakos Investigational Site

Concord, North Carolina 28027

0 studies enrolling now · 2 studies all time

What they study most

Eosinophilic Duodenitis, Eosinophilic Gastritis, Eosinophilic Gastroenteritis

Studies at this site

• A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis — Completed
• A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis — Withdrawn before enrolling